Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1979 Feb;31(1):8-10.

Adjuvant Therapy in Colorectal Cancer. (A Randomized Trial Comparing Radio-Chemotherapy and Radio-Chemotherapy Combined With the Methanol Extraction Residue of BCG, MER)

  • PMID: 383171
Clinical Trial

Adjuvant Therapy in Colorectal Cancer. (A Randomized Trial Comparing Radio-Chemotherapy and Radio-Chemotherapy Combined With the Methanol Extraction Residue of BCG, MER)

E Robinson et al. Biomedicine. .

Abstract

Fifty-three patients with colorectal cancer Dukes' B2 and C were randomized after surgery. One group was treated by radio-and/or chemotherapy and the second by radio-and/or chemotherapy and MER. After 24 and 36 months a significant longer disease free interval, lower recurrence rate and better survival was found in the group treated by radio-chemo- and immunotherapy. Treatment was well tolerated and there were few local side effects from the MER injections. The long time efficacy of this adjuvant treatment whether it increases the cure rate or only delays recurrence does require longer follow-up.

Similar articles

See all similar articles

Cited by 3 articles

Feedback